Effect of intra-articular injection of AOD9604 with or without hyaluronic acid in rabbit osteoarthritis model
Kwon DR, Park GY
Annals of Clinical and Laboratory Science (2015) · n=32
In 32 rabbits with collagenase-induced knee osteoarthritis, combined weekly intra-articular AOD-9604 plus hyaluronic acid produced better histological cartilage and lameness scores than either agent alone — the only published animal-model evidence for AOD-9604's post-obesity-program orthopaedic indication.
This is a 2015 preclinical paper in Annals of Clinical and Laboratory Science by Kwon and Park (Catholic University of Daegu and Daegu Catholic University Medical Center, Korea) testing whether intra-articular AOD-9604 — alone or in combination with hyaluronic acid — produces measurable cartilage-protective effects in a rabbit knee osteoarthritis model. The paper is the load-bearing piece of preclinical evidence behind the post-obesity-program orthopaedic indication that Metabolic Pharmaceuticals and successor licensees explored as a pivot pathway after the 2007 Phase IIb obesity-trial failure.
The methodology used 32 New Zealand white rabbits with collagenase-induced knee osteoarthritis, a standard chemically-induced cartilage-degradation model. Animals were randomised across four arms — saline control, hyaluronic acid alone, AOD-9604 alone, and AOD-9604 plus hyaluronic acid — and received weekly intra-articular injections over four to seven weeks. The endpoints were lameness severity, gross morphological scoring of articular cartilage, and histopathological scoring (Mankin-style cartilage grading from haematoxylin and eosin and safranin-O stained sections). The reported result is that the combination AOD-9604 plus hyaluronic acid arm produced significantly better morphological and histopathological scores and reduced lameness severity relative to either single-agent arm; AOD-9604 alone was not clearly superior to hyaluronic acid alone, but the combination outperformed both monotherapies on the cartilage-protection endpoints the authors measured. The authors interpret the result as preliminary support for an intra-articular AOD-9604 indication in osteoarthritis.
This is the only animal-model evidence for AOD-9604 in osteoarthritis that the published literature contains. The corresponding human-controlled-trial evidence for intra-articular AOD-9604 in osteoarthritis does not yet exist. The orthopaedic claim that the molecule supports cartilage in clinical use rests, as of 2026, on this single rabbit study together with extrapolation from the broader hyaluronic-acid intra-articular literature.
This is a rabbit-model preclinical study with a small sample (n=32 distributed across four arms, n=8 per arm) and a chemically-induced cartilage-degradation model that does not map cleanly onto the polygenic, age-related, biomechanically-driven osteoarthritis that drives most human disease. Collagenase models reliably produce cartilage degradation but the regenerative biology of the rabbit knee differs from the human knee in ways that frequently confound translation — most intra-articular candidates that look effective in rabbit collagenase models do not replicate in human osteoarthritis trials. The mechanism by which AOD-9604 would protect cartilage is not specified beyond the observation that the combination outperformed either agent alone, and the paper does not address whether the effect operates through direct chondrocyte activity, anti-inflammatory action, or potentiation of hyaluronic acid's known intra-articular biology. The intra-articular-OA indication track for AOD-9604 has not progressed beyond this kind of preclinical exploration to a published controlled human trial, and the /peptides/aod-9604 page treats this study as the only orthopaedic-adjacent evidence in the file rather than as a validation of clinical use. Single-laboratory replication caveat applies: the rabbit result has not been independently reproduced by an unaffiliated group at the time of writing.
07·Member discussion
No member discussion yet.
Member-only conversation lives here — cycle notes, practitioner commentary, pattern-matching. Be the first paying member to start the thread.